OCU410ST — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-28 in 3mo
ESTIMATED |
READOUT
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Di
Phase 2/3 · Stargardt Disease |
OCGN Ocugen, Inc. | OCU410ST |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|